Word: fda
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
That may soon change. Researchers are looking beyond aspirin and other multipurpose medications to experimental drugs that block inflammation more precisely. Any day now, Genentech is expecting a decision from the FDA on its colon-cancer drug, Avastin, which targets one of the growth factors released by the body as inflammation gives way to healing. Millennium Pharmaceuticals is testing a different kind of drug, called Velcade, which has already been approved for treating multiple myeloma, against lung cancer and other malignancies. But there is a sense that much more basic research into the nature of inflammation needs to be done...
More bad news for hormone-replacement therapy. The FDA has asked makers of HRT pills (most of which contain the hormones progestin and estrogen) to add another warning to their labels: that HRT may raise the risk of dementia in older women. A watershed 2002 study had already linked the drugs to increased risk of breast cancer, heart attack and stroke, leading experts to conclude that for many women the risks of long-term use outweigh the benefits. The recent FDA directive was based on data published last year in the Journal of the American Medical Association showing that women...
...drugs will be in the pipeline when we need them. Can any other system, including government-run labs, produce such a cornucopia of lifesaving and life-enhancing cures at any price? Studies have shown that it costs $800 million to create a new drug and get it through FDA approval. Your story promoted Soviet-style price controls. Remove incentives, and you will get Soviet-style results and products. As a practicing physician and surgeon, I'll take a capitalist drug company for my patients every time. CHRISTOPHER LYON, M.D. Newport Beach, Calif...
...Food and Drug Administration (FDA) issued a negative ruling on ImClone's experimental anticancer drug. The shares tanked after ImClone disclosed that news. Stewart saved at least $45,000 by selling her shares when she did, for $58.43. A few days after the sale, Merrill Lynch compliance officials quizzed Faneuil about the transaction. He then conferred privately with Bacanovic, who insisted the sale had been made to help Stewart offset taxes on other stock gains. But when Stewart's financial adviser angrily complained to Faneuil that the ImClone shares had been sold at a profit and "screwed up" previous...
...their troubles, has rebounded. Encouraging research on its colon-cancer drug Erbitux has sent the stock price back up to about $41, after it plunged to as little as $6 in the fall of 2002. This week, as federal prosecutors try to bottle up Stewart, another federal agency, the FDA, could release Erbitux for the public benefit...